US 12,138,228 B2
Drug imaging device and drug packaging device
Naoki Koike, Osaka (JP); Masao Fukada, Osaka (JP); Ryosuke Fukamori, Osaka (JP); and Thanhxuan Huynh, Osaka (JP)
Assigned to YUYAMA MFG. CO., LTD., Osaka (JP)
Appl. No. 18/043,897
Filed by YUYAMA MFG. CO., LTD., Osaka (JP)
PCT Filed Sep. 3, 2021, PCT No. PCT/JP2021/032393
§ 371(c)(1), (2) Date Mar. 2, 2023,
PCT Pub. No. WO2022/050371, PCT Pub. Date Mar. 10, 2022.
Claims priority of application No. 2020-148162 (JP), filed on Sep. 3, 2020; and application No. 2021-139595 (JP), filed on Aug. 30, 2021.
Prior Publication US 2023/0320936 A1, Oct. 12, 2023
Int. Cl. A61J 3/00 (2006.01); A61J 3/07 (2006.01); B65B 1/30 (2006.01); B65B 5/10 (2006.01); G06T 7/00 (2017.01)
CPC A61J 3/074 (2013.01) [B65B 1/30 (2013.01); B65B 5/103 (2013.01); G06T 7/0012 (2013.01); G06T 2207/30242 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A drug imaging device comprising:
an imaging unit configured for image capture of a drug, wherein the imaging unit is configured to perform
a first imaging process of capturing, in a non-backlit state, a first image of the drug in a pooling portion configured to temporarily pool the drug before packaging, and
a second imaging process of capturing, in a backlit state, a second image of the drug in the pooling portion;
wherein the imaging unit is further configured such that
the first imaging process includes capturing the first image of the drug in the pooling portion from one side in the non-backlit state, and
the second imaging process includes capturing the second image of the drug in the pooling portion from the one side in the backlit state; and
wherein the imaging unit is further configured to perform a third imaging process of capturing a third image of the drug in the pooling portion from another side in the non-backlit state.